Objective This study aimed to evaluate the clinical effect of hyaluronic acid(HA)scaffold combined with adipose-derived stem cells(ADSCs)in chronic wound healing of lower limbs and explore its applica-tion potential in promoting chronic wound healing.Methods A total of 50 patients were included in this study.They were divided into study and control groups according to the random number table method.There were 25 cases in each of the two groups of patients.HA and ADSCs were mixed in a 1:1 ratio and evenly injected into the wound base and the subcutaneous tissue around the wound at a rate of 0.1 ml/cm3.In the control group,ADSCs were only injected into the wound base and subcutaneous tissue around the wound.The infection rate,treatment satisfaction,wound healing rate,visual analogue score(VAS),and wound quantitative score were compared between the two groups at 7 days,14 days,and 28 days.Results The infection rate in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).Moreover,at 14 days and 28 days after treatment,the wound healing rate in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).On the 7th,14th,and 28th days after treatment,the VAS scores and the wound quantitative scores were lower than those in the control group,and the difference was statisti-cally significant(P<0.05).Furthermore,the treatment satisfaction rate in the research group(92％)was higher than that in the control group(80％).Conclusion HA scaffold combined with ADSCs could promote the healing of chronic wounds in lower limbs,reduce infection rate,and relieve wound pain,which provides a new idea for the treatment of chronic wounds.

Objective This study aimed to evaluate the clinical effect of hyaluronic acid(HA)scaffold combined with adipose-derived stem cells(ADSCs)in chronic wound healing of lower limbs and explore its applica-tion potential in promoting chronic wound healing.Methods A total of 50 patients were included in this study.They were divided into study and control groups according to the random number table method.There were 25 cases in each of the two groups of patients.HA and ADSCs were mixed in a 1:1 ratio and evenly injected into the wound base and the subcutaneous tissue around the wound at a rate of 0.1 ml/cm3.In the control group,ADSCs were only injected into the wound base and subcutaneous tissue around the wound.The infection rate,treatment satisfaction,wound healing rate,visual analogue score(VAS),and wound quantitative score were compared between the two groups at 7 days,14 days,and 28 days.Results The infection rate in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).Moreover,at 14 days and 28 days after treatment,the wound healing rate in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).On the 7th,14th,and 28th days after treatment,the VAS scores and the wound quantitative scores were lower than those in the control group,and the difference was statisti-cally significant(P<0.05).Furthermore,the treatment satisfaction rate in the research group(92％)was higher than that in the control group(80％).Conclusion HA scaffold combined with ADSCs could promote the healing of chronic wounds in lower limbs,reduce infection rate,and relieve wound pain,which provides a new idea for the treatment of chronic wounds.

Objective:To evaluate the reliability and validity of the simplified Chinese version of Lymphedema function, disability and health questionnaire for lower limb lymphedema (Lymph-ICF-LL).Methods:The original English version was translated into mandarin and modified to accommodate Chinese customs. According to the inclusion and exclusion criteria, 61 patients with lower extremity lymphedema who were treated in the Department of Burn and Plastic Surgery of Xi’an Central Hospital from June 2019 to June 2021 were recruited in this study. The questionnaires filled by the included patients were classified as sample 1 to sample 4 by the screening process. The valid simplified Chinese version of Lymph-ICF-LL was collected as sample 1 ( n=55), including 1 male and 54 females, aged (51.0±9.4) years (24-70 years). Among the 55 patients, 28 patients underwent lymphaticovenular anastomosis (LVA). The simplified Chinese version of Lymph-ICF-LL completed before and follow-up of 6 months after surgery were selected as sample 2 and sample 3( n=28), respectively. The simplified Chinese version of lymphoedema quality of life questionnaire (LYMQOL) filled out by the patients in sample 1 was used as sample 4 ( n=55). The reliability was analyzed by internal consistency test reliability and split-half reliability, Cronbach’s α coefficient ≥0.80 indicated good internal consistency reliability and the Spearman-Brown split-half reliability coefficient ≥0.70 indicated good split-half reliability. The content validity of the Lymph-ICF-LL was determined by three plastic surgery experts who judged the consistency of the questionnaire with the original English content. Exploratory factor analysis and criterion validity were used to analyze construct validity. For criterion validity assessment, Pearson correlation analysis was used to test the correlation between the Lymph-ICF-LL scores in sample 1 and the LYMQOL scores in sample 4. The scores of Lymph-ICF-LL before and half a year after lymphadenectomy were compared by paired t-test. Results:(1) Cronbach’s alpha was 0.937, indicating good internal consistency. The Spearman-Brown split-half reliability coefficient of the total scale was 0.700, indicating good split-half reliability. (2) The content validity of the simplified Chinese version of Lymph-ICF-LL was good. Five factors (physical function, mental function, general tasks/household, mobility and life/social life) were identified by factor analysis. The total score of the simplified Chinese version of Lymph-ICF-LL was positively correlated with the score of the simplified Chinese version of LYMQOL ( r=0.73, P<0.001), and the criterion correlation validity was good. (3) The scores of Lymph-ICF-LL for half a year after LVA was significantly lower than its preoperative counterparts (40.70±15.13 vs. 54.40±15.70, t=5.96, P<0.001). The quality of life of patients after LVA was significantly improved. Conclusion:The simplified Chinese version of Lymph-ICF-LL shows good reliability and validity and can be used to evaluate the quality of daily life regarding patients with lower limb lymphedema.

Objective:To evaluate the reliability and validity of the simplified Chinese version of Lymphedema function, disability and health questionnaire for lower limb lymphedema (Lymph-ICF-LL).Methods:The original English version was translated into mandarin and modified to accommodate Chinese customs. According to the inclusion and exclusion criteria, 61 patients with lower extremity lymphedema who were treated in the Department of Burn and Plastic Surgery of Xi’an Central Hospital from June 2019 to June 2021 were recruited in this study. The questionnaires filled by the included patients were classified as sample 1 to sample 4 by the screening process. The valid simplified Chinese version of Lymph-ICF-LL was collected as sample 1 ( n=55), including 1 male and 54 females, aged (51.0±9.4) years (24-70 years). Among the 55 patients, 28 patients underwent lymphaticovenular anastomosis (LVA). The simplified Chinese version of Lymph-ICF-LL completed before and follow-up of 6 months after surgery were selected as sample 2 and sample 3( n=28), respectively. The simplified Chinese version of lymphoedema quality of life questionnaire (LYMQOL) filled out by the patients in sample 1 was used as sample 4 ( n=55). The reliability was analyzed by internal consistency test reliability and split-half reliability, Cronbach’s α coefficient ≥0.80 indicated good internal consistency reliability and the Spearman-Brown split-half reliability coefficient ≥0.70 indicated good split-half reliability. The content validity of the Lymph-ICF-LL was determined by three plastic surgery experts who judged the consistency of the questionnaire with the original English content. Exploratory factor analysis and criterion validity were used to analyze construct validity. For criterion validity assessment, Pearson correlation analysis was used to test the correlation between the Lymph-ICF-LL scores in sample 1 and the LYMQOL scores in sample 4. The scores of Lymph-ICF-LL before and half a year after lymphadenectomy were compared by paired t-test. Results:(1) Cronbach’s alpha was 0.937, indicating good internal consistency. The Spearman-Brown split-half reliability coefficient of the total scale was 0.700, indicating good split-half reliability. (2) The content validity of the simplified Chinese version of Lymph-ICF-LL was good. Five factors (physical function, mental function, general tasks/household, mobility and life/social life) were identified by factor analysis. The total score of the simplified Chinese version of Lymph-ICF-LL was positively correlated with the score of the simplified Chinese version of LYMQOL ( r=0.73, P<0.001), and the criterion correlation validity was good. (3) The scores of Lymph-ICF-LL for half a year after LVA was significantly lower than its preoperative counterparts (40.70±15.13 vs. 54.40±15.70, t=5.96, P<0.001). The quality of life of patients after LVA was significantly improved. Conclusion:The simplified Chinese version of Lymph-ICF-LL shows good reliability and validity and can be used to evaluate the quality of daily life regarding patients with lower limb lymphedema.